Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production

Exclusion Criteria

• •1. History or presence of alcoholism or substance abuse disorder within the last year.
• •2. Positive urine drug screen at Screening or Check-In.
• •3. Subject is currently actively using MCTs, ketone esters, or other ketogenic products or is following a ketogenic diet.
• •4. Clinically significant abnormal laboratory results at Screening that in the opinion of the PI preclude participating in this study
• •5. Participation in another clinical trial within 30 days prior to Check-In.
• •6. Subject has a known allergy to the study drug's active or inactive ingredients.
• •7. Subject has been following a ketogenic diet (or other diet incompatible with the on-study diet), in the opinion of the investigator.
• •8. Unable to refrain from, or anticipates the use of drugs other than allowed products, including prescription and non-prescription medications, beginning 14 days prior to the first dose and throughout the study.
• •1. Allowed medications include anti-hypertensive agents, statins, aspirin in a dose of 100 mg or less per day for prophylaxis.
• •2. Paracetamol (acetaminophen), up to 4 g per 24 hour period, or ibuprofen (up to 1200 mg per 24-hour period) may be permitted during the study.
• •3. Herbal remedies and vitamin supplements are permitted in usual doses (not hyper supplementation) so long as subject has been on stable amounts for at least 6 weeks.
• •4. Agents being taken to improve memory or cognition are not allowed, whether herbal, 'natural' or pharmaceutical.
• •9. Subject is known HIV, HBV or HCV positive, or has a positive test at Screening.
• •10. Any other condition which, in the investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject.